These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6229678)
21. The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties. Valchár M; Krejcí I; Kasafírek E; Schuh J; Dlabac A Pol J Pharmacol Pharm; 1985; 37(3):311-5. PubMed ID: 2866500 [TBL] [Abstract][Full Text] [Related]
22. Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat. Bhargava HN; Ramarao P Peptides; 1989; 10(4):767-71. PubMed ID: 2573893 [TBL] [Abstract][Full Text] [Related]
23. Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse. Bhargava HN Neuropharmacology; 1982 Mar; 21(3):227-33. PubMed ID: 6122186 [TBL] [Abstract][Full Text] [Related]
24. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
25. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat. Chesselet MF; Chéramy A; Reisine TD; Lubetzki C; Desban M; Glowinski J Brain Res; 1983 Jan; 258(2):229-42. PubMed ID: 6824913 [TBL] [Abstract][Full Text] [Related]
26. The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice. Ritzmann RF; Bhargava HN Life Sci; 1980 Dec; 27(22):2075-80. PubMed ID: 6782403 [No Abstract] [Full Text] [Related]
27. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
28. Modulation of dopamine release in rat striatal slices by delta opiate agonists. Lubetzki C; Chesselet MF; Glowinski J J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911 [TBL] [Abstract][Full Text] [Related]
29. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding. Bean AJ; Elgin RJ; Cooper DM; Martin GE Peptides; 1987; 8(1):39-44. PubMed ID: 3575153 [TBL] [Abstract][Full Text] [Related]
30. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat. Bhargava HN; Kim HS J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229 [TBL] [Abstract][Full Text] [Related]
31. Long-term changes of striatal D-2 receptors in rats chronically exposed to morphine under aversive life conditions. Kiyatkin EA; Belyi VP; Rusakov DYu ; Maksimov VV; Pankratova NV; Rozhanets VV Int J Neurosci; 1991 May; 58(1-2):55-61. PubMed ID: 1834600 [TBL] [Abstract][Full Text] [Related]
32. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves. Drucker GE; Ritzmann RF; Wichlinski LJ; Engh K; Gordon JH; Fields JZ Pharmacol Biochem Behav; 1994 Jan; 47(1):141-5. PubMed ID: 8115415 [TBL] [Abstract][Full Text] [Related]
33. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Verma A; Kulkarni SK Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459 [TBL] [Abstract][Full Text] [Related]
34. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations. Gandolfi O; Roncada P; Dall'Olio R; Montanaro N Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768 [TBL] [Abstract][Full Text] [Related]
35. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment. Groppetti A; Ceresoli G; Mandelli V; Parenti M J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953 [TBL] [Abstract][Full Text] [Related]
36. Effect of cyclo(Leu-Gly) on cyclic GMP-phosphodiesterase activity changes associated with development of tolerance to morphine-induced antinociception, catalepsy, respiratory depression and mydriasis. Burton CK; Ho IK; Hoskins B J Pharmacol Exp Ther; 1991 Sep; 258(3):871-6. PubMed ID: 1653844 [TBL] [Abstract][Full Text] [Related]
37. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density. Prasad C; Spahn SA; Ikegami H Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303 [TBL] [Abstract][Full Text] [Related]
38. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum. Meller E; Friedman E Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921 [TBL] [Abstract][Full Text] [Related]
39. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. Bhargava HN Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774 [TBL] [Abstract][Full Text] [Related]
40. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]